Onyx plans commercial API manufacture
Onyx Scientific has revealed that it has been engaging with the UK Medicines & Healthcare Products Regulatory Agency (MHRA) with a view to securing a commercial API licence by the end of 2019.
Ardena launches Ardena LSI
Belgian CDMO Ardena has launched Ardena LSI, which it describes as “a new business arm dedicated to the sale of chemical ingredients and intermediates for the life science industry”.
RohnerChem ceases operations after environmental issues
Swiss fine chemicals firm RohnerChem announced on 24 June 2019 that it is ceasing operations after 113 years.
Ampac reopens Virginia site
US-based API manufacturer Ampac Fine Chemicals (AFC) has officially reopened the manufacturing operations of its AFC-Virginia facility in front of state and local dignitaries and other guests.
Seqens opens ‘I&D’ centre
Seqens has officially opened its main innovation and development (I&D) centre called Seqens’Lab at Porcheville with a ribbon-cutting ceremony performed by Agnès Pannier-Runacher, secretary of state to the Minister of Economy & Finance.
Lonza invests more in HPAPIs
Lonza is to expand high potency API (HPAPI) capacity at its main site at Visp, Switzerland, in response to demand.
What does digitization mean for the chemicals industry?
In partnership with consulting firm EY, we're conducting a survey of the state of digtalization in the chemicals industry and we need your help! It is confidential, based on mainly multiple choice questions and should only take 5 minutes to complete.
